The Virology Laboratory Core provides virologic, immunologic, and molecular laboratory testing for HSV and HIV in 3 well established, accredited diagnostic laboratories; each directed by University of Washington (UW) faculty involved in this Program Project: the UW Virology Laboratory at Children's Hospital and Medical Center (CHMC; directed by Dr. R Ashley), the UW Retrovirology Laboratory at University of Washington Health Sciences Center (directed by Drs. R. Coombs and L. Corey)) and the Molecular Virology Laboratory at the Fred Hutchinson Cancer Research Center (FHCRC; directed by Dr. L. Corey). The CHMC lab will perform HSV isolation, serology, and antiviral sensitivity testing to diagnose and characterize HSV infections in subjects enrolled in Project I-IV. The UW Retrovirology Lab will perform HSV PCR, in situ HSV PCR< and HSV restriction enzyme analyses. Lab testing at these 3 sites will be supplemented by specialized testing performed in the research laboratories of Dr. R. Ashley at CHMC (mucosal antibody testing) and Dr. D. Koelle at FHCRC (CD8+ pCTL testing). Testing performed in these 5 sites will follow uniform practices of quality assurance and quality control which are established and reviewed biannually by the College of American Pathologists for accreditation of our diagnostic testing services. Accesioning of specimens, specimen handling and banking, specimen retrieval, and reporting will be performed according to uniform guidelines to assure accurate test results as well as smooth electronic data transfer between laboratories and the data management team; between laboratories and investigators involved in Projects I-IV, and between data management and the Administrative Core.

Project Start
2002-04-01
Project End
2003-03-31
Budget Start
Budget End
Support Year
12
Fiscal Year
2002
Total Cost
$228,401
Indirect Cost
Name
Fred Hutchinson Cancer Research Center
Department
Type
DUNS #
075524595
City
Seattle
State
WA
Country
United States
Zip Code
98109
Schiffer, Joshua T; Swan, Dave A; Roychoudhury, Pavitra et al. (2018) A Fixed Spatial Structure of CD8+ T Cells in Tissue during Chronic HSV-2 Infection. J Immunol 201:1522-1535
Traidl, Stephan; Kienlin, Petra; Begemann, Gabriele et al. (2018) Patients with atopic dermatitis and history of eczema herpeticum elicit herpes simplex virus-specific type 2 immune responses. J Allergy Clin Immunol 141:1144-1147.e5
Ramchandani, Meena; Selke, Stacy; Magaret, Amalia et al. (2018) Prospective cohort study showing persistent HSV-2 shedding in women with genital herpes 2 years after acquisition. Sex Transm Infect 94:568-570
Boucoiran, Isabelle; Mayer, Bryan T; Krantz, Elizabeth M et al. (2018) Nonprimary Maternal Cytomegalovirus Infection After Viral Shedding in Infants. Pediatr Infect Dis J 37:627-631
Kleinstein, Sarah E; Shea, Patrick R; Allen, Andrew S et al. (2018) Genome-wide association study (GWAS) of human host factors influencing viral severity of herpes simplex virus type 2 (HSV-2). Genes Immun :
Agyemang, Elfriede; Le, Quynh-An; Warren, Terri et al. (2017) Performance of Commercial Enzyme-Linked Immunoassays for Diagnosis of Herpes Simplex Virus-1 and Herpes Simplex Virus-2 Infection in a Clinical Setting. Sex Transm Dis 44:763-767
Stankiewicz Karita, Helen C; Moss, Nicholas J; Laschansky, Ellen et al. (2017) Invasive Obstetric Procedures and Cesarean Sections in Women With Known Herpes Simplex Virus Status During Pregnancy. Open Forum Infect Dis 4:ofx248
Looker, Katharine J; Magaret, Amalia S; May, Margaret T et al. (2017) First estimates of the global and regional incidence of neonatal herpes infection. Lancet Glob Health 5:e300-e309
Aravantinou, Meropi; Mizenina, Olga; Calenda, Giulia et al. (2017) Experimental Oral Herpes Simplex Virus-1 (HSV-1) Co-infection in Simian Immunodeficiency Virus (SIV)-Infected Rhesus Macaques. Front Microbiol 8:2342
Gottlieb, Sami L; Johnston, Christine (2017) Future prospects for new vaccines against sexually transmitted infections. Curr Opin Infect Dis 30:77-86

Showing the most recent 10 out of 345 publications